GlassScriptPhysician profile
Donald R Ansert
NPI 1508838939
$18,067.21
in general payments reported to CMS, 2019-2025
58 companies · $2,618 in 2025
The $2,618 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,451 · 2020: $5,160 · 2021: $988 · 2022: $1,943 · 2023: $2,171 · 2024: $2,736 · 2025: $2,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,502 · Education: $23.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,501.75 |
| Education | $23.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,123.02 | 2020 | |
| Stryker Corporation | $1,638.30 | 2019-2025 | Variax, Easyfuse, Ortholoc 2 Lapifuse |
| Horizon Therapeutics Plc | $1,302.13 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $1,265.94 | 2020-2025 | Nuzyra |
| Organogenesis INC. | $1,115.86 | 2019-2025 | Puraply, Novachor, Simplimax |
| Alpha Orthopedic Systems | $959.52 | 2019-2024 | |
| Smith+Nephew, INC. | $871.77 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Tactile Systems Technology INC | $759.46 | 2019-2025 | Nimbl, Flexitouch Plus |
| Abbvie INC. | $469.87 | 2021-2025 | Dalvance |
| Integra Lifesciences Corporation | $436.88 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $424.98 | 2023-2025 | Motoband, Na, N/A |
| Bone Support INC. | $364.00 | 2022-2025 | Cerament G, Ceramentbone Void Filler |
| Inari Medical, INC. | $357.16 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Wright Medical Technology, INC. | $340.07 | 2019-2020 | |
| Misonix INC | $315.16 | 2020 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $278.25 | 2023-2025 | |
| Treace Medical Concepts, INC. | $272.43 | 2023-2025 | |
| Kerecis Limited | $263.40 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Sebela Pharmaceuticals INC. | $258.64 | 2019-2023 | Pramosone, Naftin |
| Medtronic, INC. | $255.13 | 2022-2024 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $242.67 | 2024-2025 | |
| Sanara Medtech INC. | $221.29 | 2022-2024 | Celleraterx, Texagen |
| Nevro Corp. | $215.05 | 2021-2024 | Senza |
| Bioventus LLC | $198.34 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Zyla Life Sciences, INC. | $196.18 | 2019-2020 | |
| Blue Surgical LLC | $170.01 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $166.64 | 2022 | |
| Pfizer INC. | $158.83 | 2019-2020 | |
| Medline Industries LP | $138.66 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $137.20 | 2021-2023 | Jublia |
| Triad Life Sciences INC. | $121.46 | 2022 | |
| Melinta Therapeutics, LLC | $108.10 | 2019-2022 | |
| Royal Biologics, INC. | $95.54 | 2025 | |
| Amgen INC. | $80.20 | 2024-2025 | Krystexxa |
| Mimedx Group, INC. | $76.10 | 2024 | |
| Allergan, INC. | $64.39 | 2020 | |
| Reprise Biomedical, INC. | $64.11 | 2024-2025 | Miro3d |
| Encore Dermatology INC. | $59.18 | 2020 | |
| Boston Scientific Corporation | $58.26 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Next Science LLC | $55.48 | 2023-2024 | Surgx, Xperience, Blastx |
| Acera Surgical, INC. | $45.12 | 2021 | |
| Abbott Laboratories | $40.24 | 2022-2023 | Octrode |
| Surgenex LLC | $28.45 | 2025 | Surmatrix, Renograft, Ardeograft |
| Nabriva Therapeutics, Plc | $26.70 | 2021-2022 | |
| Celularity INC. | $24.00 | 2019 | |
| Averitas Pharma INC. | $21.16 | 2024 | Qutenza |
| Mckesson Patient Care Solutions INC. | $20.15 | 2019 | |
| Medtronic Vascular, INC. | $20.09 | 2019 | |
| Sandoz INC. | $17.70 | 2020 | |
| Glaxosmithkline, LLC. | $17.42 | 2022 | |
| Medartis INC. | $15.49 | 2019 | |
| La Jolla Pharmaceutical Company | $14.91 | 2020 | |
| Alfasigma USA, INC. | $14.61 | 2022 | |
| Globus Medical, INC. | $14.22 | 2025 | Senza |
| Paragon 28, INC. | $13.43 | 2020 | |
| Aroa Biosurgery Incorporated | $13.05 | 2019 | |
| Hikma Pharmaceuticals USA | $11.71 | 2020 | |
| Orthofix Medical, INC. | $9.10 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Ansert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.